NFE2L2 and osteoporosis: Dehydrocostus lactone has been proved to inhibit the NF-κB pathway by scavenging ROS, activating Nrf2, and downregulating IKK and JNK, thereby inhibiting differentiation of osteoclasts and treating diseases such as osteoporosis caused by excessive activity of osteoclasts (Lee et al., 2020).